(Published in Part II, Section 3, Sub Section (ii) of the
Gazette of India Extraordinary)

Government of India
Ministry of Chemicals and Fertilizers
Department of Pharmaceuticals
National Pharmaceuticals Pricing Authority

                                                                New Delhi, the 14^th July, 2014

ORDER

S.O.1827(E)  – The National Pharmaceutical Pricing Authority’s Order No. S.O. 1730(E) to 1779(E) dated the 10th July, 2014, published in the Gazette of India, Extraordinary, of the Para 15, in English version be read as follows :

Instead of

“15.     In case of failure / non-compliance of para 5 and 6 above, the manufacturer /marketer shall be liable to deposit the overcharged amount alongwith the interest thereon from the date of notification and / or date of price increase beyond 10%, as the case may be.”

Read as

“15.     In case of failure / non-compliance of para 13 and 14 above, the manufacturer /marketer shall be liable to deposit the overcharged amount alongwith the interest thereon from the date of notification and / or date of price increase beyond 10%, as the case may be.”

And also Order No. S.O. 1730(E) to 1779(E) dated the 10th July, 2014, published in the Gazette of India, Extraordinary, in the column No. (1) to (5) of the table, in Hindi version be read as follows :

Instead of

Table

*Subject to actual payment of Government levies/taxes, as applicable.

Read as

Table

* subject to actual payment of excise duty + local taxes, as applicable

PN/148/16/2014/F

F. No. 23(1)/2014/Div.III/NPPA

(Injeti Srinivas)
Chairman
National Pharmaceutical Pricing Authority